Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MUROMONAB-CD3 vs NADOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MUROMONAB-CD3 vs NADOLOL: Safety Overview

Metric MUROMONAB-CD3 NADOLOL
Total FAERS Reports 114 1,878
Deaths Reported 28 141
Death Rate 24.6% 7.5%
Hospitalizations 28 607
Average Patient Age 30.2 yrs 57.0 yrs
% Female Patients 45.0% 84.2%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A American Health Packaging
Route N/A ORAL
Marketing Status N/A Discontinued